Discover
ASMB
Assembly Biosciences, Inc.
26.47
1 x 24.77
1 x 27.00
bid
ask
+
1.41
5.63%
1 @ 04:00 PM
26.44 -0.03 (0.11%)
| Ytd | -22.17% | |
| 1y | 45.04% |
24.87
day range
26.64
16.90
52 week range
39.71
| Open | 25.00 | Prev Close | 25.06 | Low | 24.87 | High | 26.64 | Mkt Cap | 420.69M |
| Vol | 112.04K | Avg Vol | 204.29K | EPS | -0.11 | P/E | -240.64 | Forward P/E | -2.12 |
| Beta | 1.08 | Short Ratio | 0.41 | Inst. Own | 18.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 26.47 | 200-d Avg | 29.23 | 1yr Est | 35.50 |
| Income Statement | |||
| Operating Expenses | 19.58M | ||
| Research and Development Expense | 14.90M | ||
| Selling, General and Administrative Expense | 4.68M | ||
| Operating Income | -19.58M | ||
| Net Income | -9.08M | ||
| Net Income Common Stock | -9.08M | ||
| Net Income Common Stock (USD) | -9.08M | ||
| Consolidated Income | -9.08M | ||
| Earnings per Basic Share | -0.54 | ||
| Earnings per Basic Share (USD) | -0.54 | ||
| Earnings per Diluted Share | -0.54 | ||
| Earning Before Interest & Taxes (EBIT) | -9.08M | ||
| Earning Before Interest & Taxes (USD) | -9.08M | ||
| Weighted Average Shares | 16.90M | ||
| Weighted Average Shares Diluted | 16.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.12M | ||
| Cash and Equivalents (USD) | 31.12M | ||
| Investments | 195.48M | ||
| Investments Current | 195.48M | ||
| Trade and Non-Trade Receivables | 451.00K | ||
| Current Assets | 232.61M | ||
| Property, Plant & Equipment Net | 2.58M | ||
| Total Assets | 235.51M | ||
| Debt Current | 590.00K | ||
| Total Debt | 2.49M | ||
| Current Liabilities | 35.00M | ||
| Debt Non-Current | 1.90M | ||
| Total Liabilities | 36.90M | ||
| Accumulated Retained Earnings (Deficit) | -841.13M | ||
| Accumulated Other Comprehensive Income | -368.00K | ||
| Shareholders Equity | 198.61M | ||
| Shareholders Equity (USD) | 198.61M | ||
| Assets Non-Current | 2.90M | ||
| Total Debt (USD) | 2.49M | ||
| Deferred Revenue | 29.08M | ||
| Liabilities Non-Current | 1.90M | ||
| Trade and Non-Trade Payables | 1.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 26.00K | ||
| Net Cash Flow from Financing | 149.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.33M | ||
| Capital Expenditure | -19.00K | ||
| Issuance (Purchase) of Equity Shares | 149.00K | ||
| Net Cash Flow from Investing | -5.38M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -5.36M | ||
| Net Cash Flow from Operations | -22.10M | ||
| Share Based Compensation | 1.12M | ||